Evaluation of PFS and OS in patients with sporadic, advanced, unresectable, well-differentiated pancreatic neuroendocrine tumors (panNETs) treated initially with Octreotide LAR and methods of further treatment after relapse - Real-world data
JOURNAL OF NEUROENDOCRINOLOGY（2022）
Key words
advance, unresectable pancreatic neuroendocrine tumor, initial octreotide lar therapy, os, pfs
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined